Schedule 13D ownership disclosure
Benitec Biopharma LTD/ADR
Security class unavailable · CUSIP: 082053307
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-755427
- Form type
- SC 13D
- Filer
- Benitec Biopharma LTD/ADR
- CIK
- CIK 1552795
- Filed
- Nov 01, 2016
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership